Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to determine whether pediatric B-cell acute lymphoblastic leukemia (B-ALL) patients with negative deep minimal residue disease (MRD) can benefit from blinatumomab tr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Children's Hospital of Zhejiang University School of Medicine
NCT07441668 · Pediatric Intensive Care Unit, Comfort, and more
NCT07088900 · Appendectomy, Pediatric
NCT06120764 · Chemotherapy-induced Nausea and Vomiting, Pediatric Cancer
NCT03986021 · Reproductive Physiological Processes, Pediatrics, and more
NCT07489378 · Very Rare Tumors, Very Rare Cancers, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions